| Literature DB >> 26259507 |
Naoe Kaneko1, Yuki Ito1, Tomoyuki Iwasaki1, Hiroyuki Takeda2, Tatsuya Sawasaki2, Kiyoshi Migita3, Kazunaga Agematsu4, Atsushi Kawakami5, Shinnosuke Morikawa1, Sho Mokuda1, Mie Kurata1, Junya Masumoto6.
Abstract
Absent in melanoma 2 (AIM2) is an intracellular pattern-recognition receptor, which is a member of the PYHIN protein family, consisting of a PYD domain and an IFN-inducible nuclear localization (HIN) domain. AIM2 is reported to oligomerize with adaptor protein ASC upon sensing bacterial and viral cytosolic DNA in order to form the AIM2 inflammasome, which activates caspase-1 leading to IL-1β secretion. Dysregulation of AIM2 inflammasome is supposed to result in autoinflammatory and autoimmune diseases. Thus, the development of new targeted drugs against AIM2 inflammasome would be important for the treatment of these diseases. However, since AIM2 inflammasome is an intracellular receptor, enforced internalization of both ligands and candidate molecules is necessary for the screening of AIM2-inflammasome-targeted molecules. We developed a reconstituted AIM2 inflammasome in a cell-free system with amplified luminescent proximity homogeneous assay (Alpha). Strong Alpha signal was detected upon incubation with poly-deoxyadenylic-deoxythymidylic acid, poly(dA:dT), whereas no Alpha signal was detected upon incubation with muramyl dipeptide, one of the NLR ligands of Nod2 ligand. The interaction between AIM2 and ASC was disrupted by an anti-human ASC monoclonal antibody, CRID3, a class of diarylsulfonylurea-containing compounds, and glycyrrhizin, a substance found in liquorice root. Thus, the reconstituted AIM2 inflammasome in a cell-free system is useful for screening AIM2-inflammasome-targeted therapeutic molecules.Entities:
Keywords: AIM2; ASC; Cell-free; Inflammasome; Reconstitution
Mesh:
Substances:
Year: 2015 PMID: 26259507 DOI: 10.1016/j.jim.2015.08.004
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303